APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biomolecule Software

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Biomolecule Software Market Analysis and Forecast 2026-2032

1 January 2026212 pages

Choose your research edition.

Industry ResearchBiomolecule Software Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Biomolecule Software Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Biomolecule Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biomolecule Software Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Biomolecule Software Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global Biomolecule Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Biomolecule Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Biomolecule Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Biomolecule Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Biomolecule Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Biomolecule Software include Hamilton Thorne, Hermes Medical Solutions, Inc, INDICAL BIOSCIENCE, lexogen, Repligen, SCC SOFT COMPUTER, Oxford Instruments, Partek, Inc. and Stilla Technologies, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Biomolecule Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Biomolecule Software, also provides the revenue of main regions and countries. Of the upcoming market potential for Biomolecule Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biomolecule Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Biomolecule Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Biomolecule Software revenue, projected growth trends, production technology, application and end-user industry.

Biomolecule Software Segment by Company

Hamilton Thorne

Hermes Medical Solutions, Inc

INDICAL BIOSCIENCE

lexogen

Repligen

SCC SOFT COMPUTER

Oxford Instruments

Partek, Inc.

Stilla Technologies

Vela Diagnostics

Vittoriobasurto

SCIEX

SoftGenetics, LLC.

Benchling

BioSistemika

CapitalBio Technology

cytena GmbH

Eppendorf SE

GenomSys

Mission Bio

Multid Analyses AB

PhenoSystems SA

Progenie Molecular

Biomolecule Software Segment by Type

Windows

Linux

MacOS

Biomolecule Software Segment by Application

Hospital

Clinic

Research Center

Biomolecule Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomolecule Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biomolecule Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomolecule Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Biomolecule Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Biomolecule Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biomolecule Software revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biomolecule Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Windows Major Player Table 3. Linux Major Player Table 4. MacOS Major Player Table 5. Global Biomolecule Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Player Table 7. Clinic Major Player Table 8. Research Center Major Player Table 9. Biomolecule Software Industry Trends Table 10. Biomolecule Software Industry Drivers Table 11. Biomolecule Software Industry Opportunities and Challenges Table 12. Biomolecule Software Industry Restraints Table 13. Global Biomolecule Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Biomolecule Software Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Biomolecule Software Market Share by Region (2021-2026) Table 16. Global Biomolecule Software Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Biomolecule Software Market Share by Region (2027-2032) Table 18. Global Biomolecule Software Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Biomolecule Software Revenue Market Share by Players (2021-2026) Table 20. Global Biomolecule Software Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Biomolecule Software Key Players Headquarters & Area Served Table 22. Global Biomolecule Software Players, Product Type & Application Table 23. Global Biomolecule Software Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Biomolecule Software by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Biomolecule Software Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Biomolecule Software Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Biomolecule Software Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Biomolecule Software Revenue Market Share by Type (2021-2026) Table 30. Global Biomolecule Software Revenue Market Share by Type (2027-2032) Table 31. Global Biomolecule Software Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Biomolecule Software Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Biomolecule Software Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Biomolecule Software Revenue Market Share by Application (2021-2026) Table 35. Global Biomolecule Software Revenue Market Share by Application (2027-2032) Table 36. Hamilton Thorne Company Information Table 37. Hamilton Thorne Business Overview Table 38. Hamilton Thorne Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Hamilton Thorne Biomolecule Software Product Portfolio Table 40. Hamilton Thorne Recent Development Table 41. Hermes Medical Solutions, Inc Company Information Table 42. Hermes Medical Solutions, Inc Business Overview Table 43. Hermes Medical Solutions, Inc Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Hermes Medical Solutions, Inc Biomolecule Software Product Portfolio Table 45. Hermes Medical Solutions, Inc Recent Development Table 46. INDICAL BIOSCIENCE Company Information Table 47. INDICAL BIOSCIENCE Business Overview Table 48. INDICAL BIOSCIENCE Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. INDICAL BIOSCIENCE Biomolecule Software Product Portfolio Table 50. INDICAL BIOSCIENCE Recent Development Table 51. lexogen Company Information Table 52. lexogen Business Overview Table 53. lexogen Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. lexogen Biomolecule Software Product Portfolio Table 55. lexogen Recent Development Table 56. Repligen Company Information Table 57. Repligen Business Overview Table 58. Repligen Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Repligen Biomolecule Software Product Portfolio Table 60. Repligen Recent Development Table 61. SCC SOFT COMPUTER Company Information Table 62. SCC SOFT COMPUTER Business Overview Table 63. SCC SOFT COMPUTER Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. SCC SOFT COMPUTER Biomolecule Software Product Portfolio Table 65. SCC SOFT COMPUTER Recent Development Table 66. Oxford Instruments Company Information Table 67. Oxford Instruments Business Overview Table 68. Oxford Instruments Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Oxford Instruments Biomolecule Software Product Portfolio Table 70. Oxford Instruments Recent Development Table 71. Partek, Inc. Company Information Table 72. Partek, Inc. Business Overview Table 73. Partek, Inc. Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Partek, Inc. Biomolecule Software Product Portfolio Table 75. Partek, Inc. Recent Development Table 76. Stilla Technologies Company Information Table 77. Stilla Technologies Business Overview Table 78. Stilla Technologies Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Stilla Technologies Biomolecule Software Product Portfolio Table 80. Stilla Technologies Recent Development Table 81. Vela Diagnostics Company Information Table 82. Vela Diagnostics Business Overview Table 83. Vela Diagnostics Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Vela Diagnostics Biomolecule Software Product Portfolio Table 85. Vela Diagnostics Recent Development Table 86. Vittoriobasurto Company Information Table 87. Vittoriobasurto Business Overview Table 88. Vittoriobasurto Biomolecule Software Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Vittoriobasurto Biomolecule Software Product Portfolio Table 90. Vittoriobasurto Recent Development Table 91. SCIEX Company Information Table 92. SCIEX Business Overview Table 93. SCIEX Biomolecule Software Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. SCIEX Biomolecule Software Product Portfolio Table 95. SCIEX Recent Development Table 96. SoftGenetics, LLC. Company Information Table 97. SoftGenetics, LLC. Business Overview Table 98. SoftGenetics, LLC. Biomolecule Software Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. SoftGenetics, LLC. Biomolecule Software Product Portfolio Table 100. SoftGenetics, LLC. Recent Development Table 101. Benchling Company Information Table 102. Benchling Business Overview Table 103. Benchling Biomolecule Software Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Benchling Biomolecule Software Product Portfolio Table 105. Benchling Recent Development Table 106. BioSistemika Company Information Table 107. BioSistemika Business Overview Table 108. BioSistemika Biomolecule Software Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. BioSistemika Biomolecule Software Product Portfolio Table 110. BioSistemika Recent Development Table 111. CapitalBio Technology Company Information Table 112. CapitalBio Technology Business Overview Table 113. CapitalBio Technology Biomolecule Software Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. CapitalBio Technology Biomolecule Software Product Portfolio Table 115. CapitalBio Technology Recent Development Table 116. cytena GmbH Company Information Table 117. cytena GmbH Business Overview Table 118. cytena GmbH Biomolecule Software Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. cytena GmbH Biomolecule Software Product Portfolio Table 120. cytena GmbH Recent Development Table 121. Eppendorf SE Company Information Table 122. Eppendorf SE Business Overview Table 123. Eppendorf SE Biomolecule Software Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Eppendorf SE Biomolecule Software Product Portfolio Table 125. Eppendorf SE Recent Development Table 126. GenomSys Company Information Table 127. GenomSys Business Overview Table 128. GenomSys Biomolecule Software Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. GenomSys Biomolecule Software Product Portfolio Table 130. GenomSys Recent Development Table 131. Mission Bio Company Information Table 132. Mission Bio Business Overview Table 133. Mission Bio Biomolecule Software Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Mission Bio Biomolecule Software Product Portfolio Table 135. Mission Bio Recent Development Table 136. Multid Analyses AB Company Information Table 137. Multid Analyses AB Business Overview Table 138. Multid Analyses AB Biomolecule Software Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Multid Analyses AB Biomolecule Software Product Portfolio Table 140. Multid Analyses AB Recent Development Table 141. PhenoSystems SA Company Information Table 142. PhenoSystems SA Business Overview Table 143. PhenoSystems SA Biomolecule Software Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. PhenoSystems SA Biomolecule Software Product Portfolio Table 145. PhenoSystems SA Recent Development Table 146. Progenie Molecular Company Information Table 147. Progenie Molecular Business Overview Table 148. Progenie Molecular Biomolecule Software Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Progenie Molecular Biomolecule Software Product Portfolio Table 150. Progenie Molecular Recent Development Table 151. North America Biomolecule Software Revenue by Type (2021-2026) & (US$ Million) Table 152. North America Biomolecule Software Revenue by Type (2027-2032) & (US$ Million) Table 153. North America Biomolecule Software Revenue by Application (2021-2026) & (US$ Million) Table 154. North America Biomolecule Software Revenue by Application (2027-2032) & (US$ Million) Table 155. North America Biomolecule Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 156. North America Biomolecule Software Revenue by Country (2021-2026) & (US$ Million) Table 157. North America Biomolecule Software Revenue by Country (US$ Million) & (2027-2032) Table 158. Europe Biomolecule Software Revenue by Type (2021-2026) & (US$ Million) Table 159. Europe Biomolecule Software Revenue by Type (2027-2032) & (US$ Million) Table 160. Europe Biomolecule Software Revenue by Application (2021-2026) & (US$ Million) Table 161. Europe Biomolecule Software Revenue by Application (2027-2032) & (US$ Million) Table 162. Europe Biomolecule Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 163. Europe Biomolecule Software Revenue by Country (2021-2026) & (US$ Million) Table 164. Europe Biomolecule Software Revenue by Country (US$ Million) & (2027-2032) Table 165. China Biomolecule Software Revenue by Type (2021-2026) & (US$ Million) Table 166. China Biomolecule Software Revenue by Type (2027-2032) & (US$ Million) Table 167. China Biomolecule Software Revenue by Application (2021-2026) & (US$ Million) Table 168. China Biomolecule Software Revenue by Application (2027-2032) & (US$ Million) Table 169. Asia Biomolecule Software Revenue by Type (2021-2026) & (US$ Million) Table 170. Asia Biomolecule Software Revenue by Type (2027-2032) & (US$ Million) Table 171. Asia Biomolecule Software Revenue by Application (2021-2026) & (US$ Million) Table 172. Asia Biomolecule Software Revenue by Application (2027-2032) & (US$ Million) Table 173. Asia Biomolecule Software Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 174. Asia Biomolecule Software Revenue by Region (US$ Million) & (2021-2026) Table 175. Asia Biomolecule Software Revenue by Region (US$ Million) & (2027-2032) Table 176. SAMEA Biomolecule Software Revenue by Type (2021-2026) & (US$ Million) Table 177. SAMEA Biomolecule Software Revenue by Type (2027-2032) & (US$ Million) Table 178. SAMEA Biomolecule Software Revenue by Application (2021-2026) & (US$ Million) Table 179. SAMEA Biomolecule Software Revenue by Application (2027-2032) & (US$ Million) Table 180. SAMEA Biomolecule Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 181. SAMEA Biomolecule Software Revenue by Country (2021-2026) & (US$ Million) Table 182. SAMEA Biomolecule Software Revenue by Country (US$ Million) & (2027-2032) Table 183. Research Programs/Design for This Report Table 184. Authors List of This Report Table 185. Secondary Sources Table 186. Primary Sources List of Figures Figure 1. Biomolecule Software Image Figure 2. Global Biomolecule Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biomolecule Software Market Size Share 2021 VS 2025 VS 2032 Figure 4. Windows Image Figure 5. Linux Image Figure 6. MacOS Image Figure 7. Global Biomolecule Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Biomolecule Software Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Clinic Image Figure 11. Research Center Image Figure 12. Global Biomolecule Software Market Size (US$ Million) & (2021-2032) Figure 13. Global Biomolecule Software Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Biomolecule Software Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Biomolecule Software Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Biomolecule Software Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Biomolecule Software Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Biomolecule Software Revenue Market Share by Type (2021-2032) Figure 20. Global Biomolecule Software Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Biomolecule Software Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Biomolecule Software Revenue Market Share by Application (2021-2032) Figure 23. North America Biomolecule Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Biomolecule Software Revenue Share by Type (2021-2032) Figure 25. North America Biomolecule Software Revenue Share by Application (2021-2032) Figure 26. North America Biomolecule Software Revenue Share by Country (2021-2032) Figure 27. United States Biomolecule Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Biomolecule Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Biomolecule Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Biomolecule Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Biomolecule Software Revenue Share by Type (2021-2032) Figure 32. Europe Biomolecule Software Revenue Share by Application (2021-2032) Figure 33. Europe Biomolecule Software Revenue Share by Country (2021-2032) Figure 34. Germany Biomolecule Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Biomolecule Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Biomolecule Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Biomolecule Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Biomolecule Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Biomolecule Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Biomolecule Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Biomolecule Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Biomolecule Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Biomolecule Software Revenue Share by Type (2021-2032) Figure 44. China Biomolecule Software Revenue Share by Application (2021-2032) Figure 45. Asia Biomolecule Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Biomolecule Software Revenue Share by Type (2021-2032) Figure 47. Asia Biomolecule Software Revenue Share by Application (2021-2032) Figure 48. Asia Biomolecule Software Revenue Share by Region (2021-2032) Figure 49. Japan Biomolecule Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Biomolecule Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Biomolecule Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Biomolecule Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Biomolecule Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Biomolecule Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Biomolecule Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Biomolecule Software Revenue Share by Type (2021-2032) Figure 57. SAMEA Biomolecule Software Revenue Share by Application (2021-2032) Figure 58. SAMEA Biomolecule Software Revenue Share by Country (2021-2032) Figure 59. Brazil Biomolecule Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Biomolecule Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Biomolecule Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Biomolecule Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Biomolecule Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Biomolecule Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Biomolecule Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Biomolecule Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Biomolecule Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Biomolecule Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Biomolecule Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Windows
  • Linux
  • MacOS
Applications
  • Hospital
  • Clinic
  • Research Center
Companies covered
  • Hamilton Thorne
  • Hermes Medical Solutions, Inc
  • INDICAL BIOSCIENCE
  • lexogen
  • Repligen
  • SCC SOFT COMPUTER
  • Oxford Instruments
  • Partek, Inc.
  • Stilla Technologies
  • Vela Diagnostics
  • Vittoriobasurto
  • SCIEX
  • SoftGenetics, LLC.
  • Benchling
  • BioSistemika
  • CapitalBio Technology
  • cytena GmbH
  • Eppendorf SE
  • GenomSys
  • Mission Bio
  • Multid Analyses AB
  • PhenoSystems SA
  • Progenie Molecular

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Biomolecule Software Market by Type
  3. 1.2.1 Global Biomolecule Software Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Windows
  5. 1.2.3 Linux
  6. 1.2.4 MacOS
  7. 1.3 Biomolecule Software Market by Application
  8. 1.3.1 Global Biomolecule Software Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Clinic
  11. 1.3.4 Research Center
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Biomolecule Software Market Dynamics
  1. 2.1 Biomolecule Software Industry Trends
  2. 2.2 Biomolecule Software Industry Drivers
  3. 2.3 Biomolecule Software Industry Opportunities and Challenges
  4. 2.4 Biomolecule Software Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Biomolecule Software Market Perspective (2021-2032)
  2. 3.2 Global Biomolecule Software Growth Trends by Region
  3. 3.2.1 Global Biomolecule Software Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Biomolecule Software Market Size by Region (2021-2026)
  5. 3.2.3 Global Biomolecule Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Biomolecule Software Revenue by Players
  2. 4.1.1 Global Biomolecule Software Revenue by Players (2021-2026)
  3. 4.1.2 Global Biomolecule Software Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Biomolecule Software Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Biomolecule Software Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Biomolecule Software Key Players Headquarters & Area Served
  7. 4.4 Global Biomolecule Software Players, Product Type & Application
  8. 4.5 Global Biomolecule Software Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Biomolecule Software Market CR5 and HHI
  11. 4.6.3 2025 Biomolecule Software Tier 1, Tier 2, and Tier 3
5 Biomolecule Software Market Size by Type
  1. 5.1 Global Biomolecule Software Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Biomolecule Software Revenue by Type (2021-2032)
  3. 5.3 Global Biomolecule Software Revenue Market Share by Type (2021-2032)
6 Biomolecule Software Market Size by Application
  1. 6.1 Global Biomolecule Software Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Biomolecule Software Revenue by Application (2021-2032)
  3. 6.3 Global Biomolecule Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Hamilton Thorne
  2. 7.1.1 Hamilton Thorne Company Information
  3. 7.1.2 Hamilton Thorne Business Overview
  4. 7.1.3 Hamilton Thorne Biomolecule Software Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Hamilton Thorne Biomolecule Software Product Portfolio
  6. 7.1.5 Hamilton Thorne Recent Developments
  7. 7.2 Hermes Medical Solutions, Inc
  8. 7.2.1 Hermes Medical Solutions, Inc Company Information
  9. 7.2.2 Hermes Medical Solutions, Inc Business Overview
  10. 7.2.3 Hermes Medical Solutions, Inc Biomolecule Software Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Hermes Medical Solutions, Inc Biomolecule Software Product Portfolio
  12. 7.2.5 Hermes Medical Solutions, Inc Recent Developments
  13. 7.3 INDICAL BIOSCIENCE
  14. 7.3.1 INDICAL BIOSCIENCE Company Information
  15. 7.3.2 INDICAL BIOSCIENCE Business Overview
  16. 7.3.3 INDICAL BIOSCIENCE Biomolecule Software Revenue and Gross Margin (2021-2026)
  17. 7.3.4 INDICAL BIOSCIENCE Biomolecule Software Product Portfolio
  18. 7.3.5 INDICAL BIOSCIENCE Recent Developments
  19. 7.4 lexogen
  20. 7.4.1 lexogen Company Information
  21. 7.4.2 lexogen Business Overview
  22. 7.4.3 lexogen Biomolecule Software Revenue and Gross Margin (2021-2026)
  23. 7.4.4 lexogen Biomolecule Software Product Portfolio
  24. 7.4.5 lexogen Recent Developments
  25. 7.5 Repligen
  26. 7.5.1 Repligen Company Information
  27. 7.5.2 Repligen Business Overview
  28. 7.5.3 Repligen Biomolecule Software Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Repligen Biomolecule Software Product Portfolio
  30. 7.5.5 Repligen Recent Developments
  31. 7.6 SCC SOFT COMPUTER
  32. 7.6.1 SCC SOFT COMPUTER Company Information
  33. 7.6.2 SCC SOFT COMPUTER Business Overview
  34. 7.6.3 SCC SOFT COMPUTER Biomolecule Software Revenue and Gross Margin (2021-2026)
  35. 7.6.4 SCC SOFT COMPUTER Biomolecule Software Product Portfolio
  36. 7.6.5 SCC SOFT COMPUTER Recent Developments
  37. 7.7 Oxford Instruments
  38. 7.7.1 Oxford Instruments Company Information
  39. 7.7.2 Oxford Instruments Business Overview
  40. 7.7.3 Oxford Instruments Biomolecule Software Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Oxford Instruments Biomolecule Software Product Portfolio
  42. 7.7.5 Oxford Instruments Recent Developments
  43. 7.8 Partek, Inc.
  44. 7.8.1 Partek, Inc. Company Information
  45. 7.8.2 Partek, Inc. Business Overview
  46. 7.8.3 Partek, Inc. Biomolecule Software Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Partek, Inc. Biomolecule Software Product Portfolio
  48. 7.8.5 Partek, Inc. Recent Developments
  49. 7.9 Stilla Technologies
  50. 7.9.1 Stilla Technologies Company Information
  51. 7.9.2 Stilla Technologies Business Overview
  52. 7.9.3 Stilla Technologies Biomolecule Software Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Stilla Technologies Biomolecule Software Product Portfolio
  54. 7.9.5 Stilla Technologies Recent Developments
  55. 7.10 Vela Diagnostics
  56. 7.10.1 Vela Diagnostics Company Information
  57. 7.10.2 Vela Diagnostics Business Overview
  58. 7.10.3 Vela Diagnostics Biomolecule Software Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Vela Diagnostics Biomolecule Software Product Portfolio
  60. 7.10.5 Vela Diagnostics Recent Developments
  61. 7.11 Vittoriobasurto
  62. 7.11.1 Vittoriobasurto Company Information
  63. 7.11.2 Vittoriobasurto Business Overview
  64. 7.11.3 Vittoriobasurto Biomolecule Software Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Vittoriobasurto Biomolecule Software Product Portfolio
  66. 7.11.5 Vittoriobasurto Recent Developments
  67. 7.12 SCIEX
  68. 7.12.1 SCIEX Company Information
  69. 7.12.2 SCIEX Business Overview
  70. 7.12.3 SCIEX Biomolecule Software Revenue and Gross Margin (2021-2026)
  71. 7.12.4 SCIEX Biomolecule Software Product Portfolio
  72. 7.12.5 SCIEX Recent Developments
  73. 7.13 SoftGenetics, LLC.
  74. 7.13.1 SoftGenetics, LLC. Company Information
  75. 7.13.2 SoftGenetics, LLC. Business Overview
  76. 7.13.3 SoftGenetics, LLC. Biomolecule Software Revenue and Gross Margin (2021-2026)
  77. 7.13.4 SoftGenetics, LLC. Biomolecule Software Product Portfolio
  78. 7.13.5 SoftGenetics, LLC. Recent Developments
  79. 7.14 Benchling
  80. 7.14.1 Benchling Company Information
  81. 7.14.2 Benchling Business Overview
  82. 7.14.3 Benchling Biomolecule Software Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Benchling Biomolecule Software Product Portfolio
  84. 7.14.5 Benchling Recent Developments
  85. 7.15 BioSistemika
  86. 7.15.1 BioSistemika Company Information
  87. 7.15.2 BioSistemika Business Overview
  88. 7.15.3 BioSistemika Biomolecule Software Revenue and Gross Margin (2021-2026)
  89. 7.15.4 BioSistemika Biomolecule Software Product Portfolio
  90. 7.15.5 BioSistemika Recent Developments
  91. 7.16 CapitalBio Technology
  92. 7.16.1 CapitalBio Technology Company Information
  93. 7.16.2 CapitalBio Technology Business Overview
  94. 7.16.3 CapitalBio Technology Biomolecule Software Revenue and Gross Margin (2021-2026)
  95. 7.16.4 CapitalBio Technology Biomolecule Software Product Portfolio
  96. 7.16.5 CapitalBio Technology Recent Developments
  97. 7.17 cytena GmbH
  98. 7.17.1 cytena GmbH Company Information
  99. 7.17.2 cytena GmbH Business Overview
  100. 7.17.3 cytena GmbH Biomolecule Software Revenue and Gross Margin (2021-2026)
  101. 7.17.4 cytena GmbH Biomolecule Software Product Portfolio
  102. 7.17.5 cytena GmbH Recent Developments
  103. 7.18 Eppendorf SE
  104. 7.18.1 Eppendorf SE Company Information
  105. 7.18.2 Eppendorf SE Business Overview
  106. 7.18.3 Eppendorf SE Biomolecule Software Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Eppendorf SE Biomolecule Software Product Portfolio
  108. 7.18.5 Eppendorf SE Recent Developments
  109. 7.19 GenomSys
  110. 7.19.1 GenomSys Company Information
  111. 7.19.2 GenomSys Business Overview
  112. 7.19.3 GenomSys Biomolecule Software Revenue and Gross Margin (2021-2026)
  113. 7.19.4 GenomSys Biomolecule Software Product Portfolio
  114. 7.19.5 GenomSys Recent Developments
  115. 7.20 Mission Bio
  116. 7.20.1 Mission Bio Company Information
  117. 7.20.2 Mission Bio Business Overview
  118. 7.20.3 Mission Bio Biomolecule Software Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Mission Bio Biomolecule Software Product Portfolio
  120. 7.20.5 Mission Bio Recent Developments
  121. 7.21 Multid Analyses AB
  122. 7.21.1 Multid Analyses AB Company Information
  123. 7.21.2 Multid Analyses AB Business Overview
  124. 7.21.3 Multid Analyses AB Biomolecule Software Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Multid Analyses AB Biomolecule Software Product Portfolio
  126. 7.21.5 Multid Analyses AB Recent Developments
  127. 7.22 PhenoSystems SA
  128. 7.22.1 PhenoSystems SA Company Information
  129. 7.22.2 PhenoSystems SA Business Overview
  130. 7.22.3 PhenoSystems SA Biomolecule Software Revenue and Gross Margin (2021-2026)
  131. 7.22.4 PhenoSystems SA Biomolecule Software Product Portfolio
  132. 7.22.5 PhenoSystems SA Recent Developments
  133. 7.23 Progenie Molecular
  134. 7.23.1 Progenie Molecular Company Information
  135. 7.23.2 Progenie Molecular Business Overview
  136. 7.23.3 Progenie Molecular Biomolecule Software Revenue and Gross Margin (2021-2026)
  137. 7.23.4 Progenie Molecular Biomolecule Software Product Portfolio
  138. 7.23.5 Progenie Molecular Recent Developments
8 North America
  1. 8.1 North America Biomolecule Software Revenue (2021-2032)
  2. 8.2 North America Biomolecule Software Revenue by Type (2021-2032)
  3. 8.2.1 North America Biomolecule Software Revenue by Type (2021-2026)
  4. 8.2.2 North America Biomolecule Software Revenue by Type (2027-2032)
  5. 8.3 North America Biomolecule Software Revenue Share by Type (2021-2032)
  6. 8.4 North America Biomolecule Software Revenue by Application (2021-2032)
  7. 8.4.1 North America Biomolecule Software Revenue by Application (2021-2026)
  8. 8.4.2 North America Biomolecule Software Revenue by Application (2027-2032)
  9. 8.5 North America Biomolecule Software Revenue Share by Application (2021-2032)
  10. 8.6 North America Biomolecule Software Revenue by Country
  11. 8.6.1 North America Biomolecule Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Biomolecule Software Revenue by Country (2021-2026)
  13. 8.6.3 North America Biomolecule Software Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Biomolecule Software Revenue (2021-2032)
  2. 9.2 Europe Biomolecule Software Revenue by Type (2021-2032)
  3. 9.2.1 Europe Biomolecule Software Revenue by Type (2021-2026)
  4. 9.2.2 Europe Biomolecule Software Revenue by Type (2027-2032)
  5. 9.3 Europe Biomolecule Software Revenue Share by Type (2021-2032)
  6. 9.4 Europe Biomolecule Software Revenue by Application (2021-2032)
  7. 9.4.1 Europe Biomolecule Software Revenue by Application (2021-2026)
  8. 9.4.2 Europe Biomolecule Software Revenue by Application (2027-2032)
  9. 9.5 Europe Biomolecule Software Revenue Share by Application (2021-2032)
  10. 9.6 Europe Biomolecule Software Revenue by Country
  11. 9.6.1 Europe Biomolecule Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Biomolecule Software Revenue by Country (2021-2026)
  13. 9.6.3 Europe Biomolecule Software Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Biomolecule Software Revenue (2021-2032)
  2. 10.2 China Biomolecule Software Revenue by Type (2021-2032)
  3. 10.2.1 China Biomolecule Software Revenue by Type (2021-2026)
  4. 10.2.2 China Biomolecule Software Revenue by Type (2027-2032)
  5. 10.3 China Biomolecule Software Revenue Share by Type (2021-2032)
  6. 10.4 China Biomolecule Software Revenue by Application (2021-2032)
  7. 10.4.1 China Biomolecule Software Revenue by Application (2021-2026)
  8. 10.4.2 China Biomolecule Software Revenue by Application (2027-2032)
  9. 10.5 China Biomolecule Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Biomolecule Software Revenue (2021-2032)
  2. 11.2 Asia Biomolecule Software Revenue by Type (2021-2032)
  3. 11.2.1 Asia Biomolecule Software Revenue by Type (2021-2026)
  4. 11.2.2 Asia Biomolecule Software Revenue by Type (2027-2032)
  5. 11.3 Asia Biomolecule Software Revenue Share by Type (2021-2032)
  6. 11.4 Asia Biomolecule Software Revenue by Application (2021-2032)
  7. 11.4.1 Asia Biomolecule Software Revenue by Application (2021-2026)
  8. 11.4.2 Asia Biomolecule Software Revenue by Application (2027-2032)
  9. 11.5 Asia Biomolecule Software Revenue Share by Application (2021-2032)
  10. 11.6 Asia Biomolecule Software Revenue by Country
  11. 11.6.1 Asia Biomolecule Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Biomolecule Software Revenue by Country (2021-2026)
  13. 11.6.3 Asia Biomolecule Software Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Biomolecule Software Revenue (2021-2032)
  2. 12.2 SAMEA Biomolecule Software Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Biomolecule Software Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Biomolecule Software Revenue by Type (2027-2032)
  5. 12.3 SAMEA Biomolecule Software Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Biomolecule Software Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Biomolecule Software Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Biomolecule Software Revenue by Application (2027-2032)
  9. 12.5 SAMEA Biomolecule Software Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Biomolecule Software Revenue by Country
  11. 12.6.1 SAMEA Biomolecule Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Biomolecule Software Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Biomolecule Software Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst